{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T16:43:12Z","timestamp":1762015392443,"version":"build-2065373602"},"reference-count":62,"publisher":"Elsevier","isbn-type":[{"type":"print","value":"9780443347672"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/bs.pbr.2025.08.001","type":"book-chapter","created":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T21:56:01Z","timestamp":1757627761000},"page":"65-93","source":"Crossref","is-referenced-by-count":0,"title":["Contributions of the endocannabinoid system to the neurobiology of emotions: Advances and perspectives"],"prefix":"10.1016","member":"78","reference":[{"issue":"8","key":"10.1016\/bs.pbr.2025.08.001_bib1","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1038\/npp.2013.51","article-title":"Cannabinoids improve impairments induced by chronic stress to synaptic plasticity and short-term memory","volume":"38","author":"Abush","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/bs.pbr.2025.08.001_bib2","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.neubiorev.2014.03.026","article-title":"Modulation of defensive behavior by transient receptor potential vanilloid type-1 (TRPV1) channels","volume":"46","author":"Aguiar","year":"2015","journal-title":"Neurosci. & Biobehav. Rev."},{"issue":"2","key":"10.1016\/bs.pbr.2025.08.001_bib3","first-page":"101","article-title":"Neurobiological mechanisms involved in the anxiolytic effects of cannabidiol","volume":"28","author":"Aguiar","year":"2014","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/bs.pbr.2025.08.001_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2019.109832","article-title":"Activation of 5-HT1A postsynaptic receptors by NLX-101 results in functional recovery and an increase in neuroplasticity in mice with brain ischemia","volume":"99","author":"Aguiar","year":"2020","journal-title":"Prog. Neuro-psychopharmacol. Biol. Psychiatry"},{"issue":"1","key":"10.1016\/bs.pbr.2025.08.001_bib5","first-page":"1","article-title":"Inhibition of neuronal endocannabinoid uptake and hydrolysis as strategies for developing anxiolytic drugs","volume":"29","author":"Batista","year":"2018","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/bs.pbr.2025.08.001_bib6","article-title":"CB2 receptors in the anterior cingulate cortex modulate the expression of contextual fear conditioning in mice","volume":"99","author":"Batista","year":"2020","journal-title":"Prog. Neuro-psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/bs.pbr.2025.08.001_bib7","first-page":"302","article-title":"Cannabinoid CB1 receptors mediate the anxiolytic effects induced by systemic alprazolam and intra-periaqueductal gray 5-HT1A receptor activation","volume":"148","author":"Batista","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/bs.pbr.2025.08.001_bib8","first-page":"1136","article-title":"Endocannabinoid signaling in the anterior cingulate cortex is involved in the modulation of acute stress-induced antinociception","volume":"9","author":"Batista","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/bs.pbr.2025.08.001_bib9","article-title":"Dual aspects of marijuana in anxiety and mood","volume":"13","author":"Braga","year":"2014","journal-title":"J. Biol."},{"issue":"7","key":"10.1016\/bs.pbr.2025.08.001_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158779","article-title":"Fluorinated cannabidiol derivatives: enhancement of activity in mice models predictive of anxiolytic, antidepressant and antipsychotic effects","volume":"11","author":"Breuer","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/bs.pbr.2025.08.001_bib11","first-page":"28","article-title":"Evidence for a potential role for TRPV1 receptors in the dorsolateral periaqueductal gray in the attenuation of the anxiolytic effects of cannabinoids","volume":"64","author":"Campos","year":"2016","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"6","key":"10.1016\/bs.pbr.2025.08.001_bib12","first-page":"550","article-title":"The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system","volume":"20","author":"Campos","year":"2017","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/bs.pbr.2025.08.001_bib13","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.eplepsyres.2016.08.011","article-title":"The cannabinoid CB2 receptor-specific agonist AM1241 increases pentylenetetrazole-induced seizure severity in wistar rats","volume":"127","author":"Carvalho","year":"2017","journal-title":"Epilepsy Res."},{"key":"10.1016\/bs.pbr.2025.08.001_bib14","first-page":"1","article-title":"Cannabinoids and traumatic stress modulation of contextual fear memory: a systematic review","volume":"11","author":"Campos","year":"2020","journal-title":"Front. Psychiatry"},{"issue":"3","key":"10.1016\/bs.pbr.2025.08.001_bib15","first-page":"282","article-title":"Interaction between neuroinflammation and the endocannabinoid system in depression: clinical implications","volume":"38","author":"Costa","year":"2016","journal-title":"Braz. J. Psychiatry"},{"issue":"1","key":"10.1016\/bs.pbr.2025.08.001_bib16","first-page":"65","article-title":"The role of the endocannabinoid system in novelty-seeking behavior and memory","volume":"37","author":"Costa","year":"2019","journal-title":"Braz. J. Psychiatry"},{"key":"10.1016\/bs.pbr.2025.08.001_bib17","first-page":"243","article-title":"Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection","volume":"93","author":"Costa","year":"2019","journal-title":"Epilepsy & Behav."},{"key":"10.1016\/bs.pbr.2025.08.001_bib18","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.tox.2015.06.005","article-title":"The psychoactive compound of cannabis sativa, \u03949-tetrahydrocannabinol (THC), inhibits human trophoblast cell turnover","volume":"334","author":"Costa","year":"2020","journal-title":"Toxicology"},{"issue":"1","key":"10.1016\/bs.pbr.2025.08.001_bib19","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/0269881110379283","article-title":"Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report","volume":"25","author":"Crippa","year":"2016","journal-title":"J. Psychopharmacol"},{"key":"10.1016\/bs.pbr.2025.08.001_bib20","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.3389\/fimmu.2018.02009","article-title":"Translational investigation of the therapeutic potential of cannabidiol (CBD): toward a new age","volume":"9","author":"Crippa","year":"2018","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/bs.pbr.2025.08.001_bib21","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/jcpt.12018","article-title":"Cannabidiol for the treatment of cannabis withdrawal syndrome: a case report","volume":"38","author":"Crippa","year":"2021","journal-title":"J. Clin. Pharm. Therapeutics"},{"issue":"5","key":"10.1016\/bs.pbr.2025.08.001_bib22","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1192\/bjp.bp.112.118307","article-title":"Late-life depression and risk of vascular dementia and alzheimer\u2019s disease: systematic review and meta-analysis of community-based cohort studies","volume":"202","author":"Diniz","year":"2019","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/bs.pbr.2025.08.001_bib23","first-page":"76","article-title":"Cannabidiol enhances exposure therapy outcomes in patients with post-traumatic stress disorder: a randomized controlled trial","volume":"135","author":"Diniz","year":"2021","journal-title":"J. Psychiatr. Res."},{"issue":"7","key":"10.1016\/bs.pbr.2025.08.001_bib24","first-page":"1480","article-title":"Biased allosteric modulation of the serotonin 5-HT2A receptor through CB1 receptor activation: implications for psychosis","volume":"43","author":"Felsing","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/bs.pbr.2025.08.001_bib25","first-page":"118","article-title":"Cannabidiol as an adjunctive treatment for schizophrenia and related psychoses: a systematic review and meta-analysis","volume":"156","author":"Ferr\u00e3o","year":"2022","journal-title":"J. Psychiatr. Res."},{"issue":"9","key":"10.1016\/bs.pbr.2025.08.001_bib26","first-page":"2341","article-title":"Effects of compounds from cannabis sativa on anxiety-like behavior: an integrative review","volume":"20","author":"Ferreira","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/bs.pbr.2025.08.001_bib27","article-title":"Endocannabinoid system as a potential target for precision medicine approaches to neuropsychiatric disorders","volume":"231","author":"Ferreira","year":"2022","journal-title":"Pharmacol.\u00a0Ther."},{"key":"10.1016\/bs.pbr.2025.08.001_bib28","first-page":"178","article-title":"Organization of ventral tegmental area projections to the ventral tegmental area-nigral complex in the rat","volume":"358","author":"Ferreira","year":"2019","journal-title":"Neuroscience"},{"key":"10.1016\/bs.pbr.2025.08.001_bib29","first-page":"84","article-title":"A concise review on FAAH\/MAGL inhibitors: from promising preclinical results to clinical studies","volume":"147","author":"Ferreira-Vieira","year":"2019","journal-title":"Neuropharmacology"},{"issue":"7","key":"10.1016\/bs.pbr.2025.08.001_bib30","first-page":"132","article-title":"FAAH genetic variation enhances fronto-amygdala function in mouse and human","volume":"12","author":"Ferreira-Vieira","year":"2020","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/bs.pbr.2025.08.001_bib31","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.neuropharm.2018.03.001","article-title":"The anxiolytic effects of cannabidiol in chronically stressed mice are mediated by the endocannabinoid system: role of neurogenesis and dendritic remodeling","volume":"135","author":"Foga\u00e7a","year":"2018","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/bs.pbr.2025.08.001_bib32","first-page":"97","article-title":"The endocannabinoid system \u2013 a therapeutic perspective","volume":"2","author":"Fonseca","year":"2017","journal-title":"Acta Farmac\u00eautica Portuguesa"},{"issue":"11","key":"10.1016\/bs.pbr.2025.08.001_bib33","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1038\/sj.npp.1300558","article-title":"Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms","volume":"29","author":"Giuffrida","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/bs.pbr.2025.08.001_bib34","unstructured":"Gomes, E.A., Baptista, E.B., 2020. The influence of the endocannabinoid system on anxiety. Repository Institutional UNIPAC."},{"key":"10.1016\/bs.pbr.2025.08.001_bib35","article-title":"The endocannabinoid system as target for the treatment of anxiety disorders: evidence from animal and human studies","volume":"405","author":"Gomes","year":"2021","journal-title":"Behavioural Brain Res."},{"issue":"10","key":"10.1016\/bs.pbr.2025.08.001_bib36","first-page":"1473","article-title":"The anxiolytic-like effects of cannabidiol injected into the bed nucleus of the stria terminalis are mediated by 5-HT1A receptors","volume":"232","author":"Gomes","year":"2015","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1016\/bs.pbr.2025.08.001_bib37","first-page":"363","article-title":"Targeting the endocannabinoid system for the treatment of psychiatric disorders: a critical review","volume":"42","author":"Guimar\u00e3es","year":"2020","journal-title":"Braz. J. Psychiatry"},{"issue":"1","key":"10.1016\/bs.pbr.2025.08.001_bib38","first-page":"153","article-title":"Nitric oxide signaling and antidepressant action revisited","volume":"371","author":"Joca","year":"2018","journal-title":"Cell Tissue Res."},{"issue":"8","key":"10.1016\/bs.pbr.2025.08.001_bib39","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1097\/00001756-199906030-00008","article-title":"Elevated endogenous cannabinoids in schizophrenia","volume":"10","author":"Leweke","year":"1999","journal-title":"Neuroreport"},{"key":"10.1016\/bs.pbr.2025.08.001_bib40","first-page":"498","article-title":"Exercise medicine for the treatment of chronic diseases: the role of brain-derived neurotrophic factor","volume":"119","author":"Lima-J\u00fanior","year":"2020","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/bs.pbr.2025.08.001_bib41","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/bs.vh.2016.09.006","article-title":"The endocannabinoid system and anxiety","volume":"103","author":"Lisboa","year":"2017","journal-title":"Vitam. Hormones"},{"issue":"1","key":"10.1016\/bs.pbr.2025.08.001_bib42","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00213-018-5127-x","article-title":"Tempering aversive\/traumatic memories with cannabinoids: a review of evidence from animal and human studies","volume":"236","author":"Lisboa","year":"2019","journal-title":"Psychopharmacology"},{"issue":"9","key":"10.1016\/bs.pbr.2025.08.001_bib43","first-page":"580","article-title":"Early phytocannabinoid chemistry to endocannabinoids and beyond","volume":"19","author":"Mechoulam","year":"2018","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/bs.pbr.2025.08.001_bib44","article-title":"Cannabidiol-enriched nanoemulsion delivered by intranasal route reduces anxiety and improves memory in rats","volume":"394","author":"Medeiros","year":"2020","journal-title":"Behav. Brain Res."},{"issue":"1","key":"10.1016\/bs.pbr.2025.08.001_bib45","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/npp.2015.166","article-title":"Neurobiological interactions between stress and the endocannabinoid system","volume":"41","author":"Morena","year":"2016","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/bs.pbr.2025.08.001_bib46","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1590\/S1516-44462009000200012","article-title":"The psychiatric side-effects of rimonabant","volume":"31","author":"Moreira","year":"2009","journal-title":"Braz. J. Psychiatry"},{"key":"10.1016\/bs.pbr.2025.08.001_bib47","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.neuroscience.2011.08.046","article-title":"Cannabinoid type 1 receptors and transient receptor potential vanilloid type 1 channels in fear and anxiety\u2014two sides of one coin?","volume":"204","author":"Moreira","year":"2012","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/bs.pbr.2025.08.001_bib48","first-page":"31","article-title":"Endocannabinoid system and cognition: from memory to forgetting. Brazilian","volume":"56","author":"N\u00f3brega","year":"2020","journal-title":"J. Neurol."},{"key":"10.1016\/bs.pbr.2025.08.001_bib49","article-title":"5-HT2 receptor activation in the midbrain periaqueductal gray (PAG) reduces anxiety-like behavior in mice","volume":"379","author":"Nunes-de-Souza","year":"2021","journal-title":"Behav. Brain Res."},{"issue":"2","key":"10.1016\/bs.pbr.2025.08.001_bib50","article-title":"Therapeutic use of cannabinoids in palliative care: a systematic review of clinical trials and prospects for the Brazilian context","volume":"67","author":"Oliveira","year":"2021","journal-title":"Rev. Brasileira de. Cancerologia"},{"key":"10.1016\/bs.pbr.2025.08.001_bib51","first-page":"74","article-title":"\u03b2-Caryophyllene, a dietary cannabinoid, complexed with \u03b2-cyclodextrin produced anti-hyperalgesic effect involving the inhibition of fos expression in superficial dorsal horn","volume":"111","author":"Oliveira","year":"2016","journal-title":"Brain Res. Bull."},{"issue":"1","key":"10.1016\/bs.pbr.2025.08.001_bib52","first-page":"35","article-title":"Cannabidiol as a treatment for bipolar disorder: a systematic review","volume":"27","author":"Pinto","year":"2020","journal-title":"Prime Psychiatry"},{"issue":"1\u20133","key":"10.1016\/bs.pbr.2025.08.001_bib53","first-page":"78","article-title":"Cannabidiol, a non-psychotropic plant-derived cannabinoid, decreases inflammation in a murine model of acute lung injury: role for the adenosine A(2A) receptor","volume":"678","author":"Ribeiro","year":"2015","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/bs.pbr.2025.08.001_bib54","first-page":"301","article-title":"Cannabinoids on pain modulation: the interaction between endocannabinoid system and opioid system","volume":"46","author":"Ribeiro","year":"2021","journal-title":"J. Clin. Pharm. Ther."},{"issue":"4","key":"10.1016\/bs.pbr.2025.08.001_bib55","first-page":"623","article-title":"THC: CBD combination therapy for multiple sclerosis related spasticity and pain: CANNAMS multicenter study results","volume":"28","author":"Santos","year":"2022","journal-title":"Mult. Scler. J."},{"key":"10.1016\/bs.pbr.2025.08.001_bib56","first-page":"24","article-title":"Anxiolytic property of ursole and anethole from croton zehntneri essential oil in male mice","volume":"38","author":"Silva","year":"2019","journal-title":"Phytomedicine"},{"key":"10.1016\/bs.pbr.2025.08.001_bib57","first-page":"903","article-title":"Cannabinoids modulate behavioral changes induced by haloperidol","volume":"8","author":"Scarante","year":"2017","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/bs.pbr.2025.08.001_bib58","article-title":"Cannabis and anxiety: a critical review of the evidence","volume":"32","author":"Spinanti","year":"2017","journal-title":"Hum. Psychopharmacol.: Clin. Exp."},{"key":"10.1016\/bs.pbr.2025.08.001_bib59","first-page":"49","article-title":"The dopamine and cannabinoid interaction in the modulation of emotions and cognition: assessing the role of cannabinoid CB1 receptor in neurons expressing dopamine D1 receptors","volume":"5","author":"Terzian","year":"2015","journal-title":"Front. Behav. Neurosci."},{"issue":"4","key":"10.1016\/bs.pbr.2025.08.001_bib60","article-title":"Cannabidiol as a treatment for post-traumatic stress disorder: a systematic review and meta-analysis","volume":"83","author":"Turna","year":"2022","journal-title":"J. Clin. Psychiatry"},{"issue":"3","key":"10.1016\/bs.pbr.2025.08.001_bib61","first-page":"313","article-title":"The endocannabinoid system in bipolar disorder: pathophysiological and therapeutic implications","volume":"43","author":"Wedy","year":"2021","journal-title":"Braz. J. Psychiatry"},{"key":"10.1016\/bs.pbr.2025.08.001_bib62","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3389\/fphar.2017.00259","article-title":"Inverted U-shaped dose-response curve of the anxiolytic effect of cannabidiol during public speaking in real life","volume":"8","author":"Zuardi","year":"2017","journal-title":"Front. Pharmacol."}],"container-title":["Progress in Brain Research","The Times They are A-Changi\u0144: On Cannabinoids and Psychedelic\u015b Therapeutic Potential and Social Impact"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0079612325001189?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0079612325001189?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T16:40:33Z","timestamp":1762015233000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0079612325001189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9780443347672"],"references-count":62,"URL":"https:\/\/doi.org\/10.1016\/bs.pbr.2025.08.001","relation":{},"ISSN":["0079-6123"],"issn-type":[{"type":"print","value":"0079-6123"}],"subject":[],"published":{"date-parts":[[2025]]}}}